MedTrace Logo

Mucosal Versus Fecal Microbiota in FMT

NCT02133651 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2015-12-09

No results posted yet for this study

Summary

Clostridium difficile infection is the most common cause of antibiotic-associated diarrhea. Treatment of this infection usually occurs using other antibiotics, but many individuals have persistent diarrhea and multiple relapses. Fecal Transplant (FMT), or Intestinal Microbiota Transplantation, (IMT) has been shown to be efficacious when administered after treatment for C. difficile. This study will involve taking biopsies from patients during their FMT/IMT via colonoscopy, and determine if there are differences in the mucosal flora as compared to the stool flora. The investigators hope to discover the critical parts of a healthy microbiota.

Conditions

  • Clostridium Difficile

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Colleen S. Kraft, MD · Emory University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02133651 on ClinicalTrials.gov